The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Barbara Schmidt

Department of Clinical Epidemiology and Biostatistics

McMaster University

Hamilton

Canada

[email]@mcmaster.ca

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada. 2001 - 2012

References

  1. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. Schmidt, B., Anderson, P.J., Doyle, L.W., Dewey, D., Grunau, R.E., Asztalos, E.V., Davis, P.G., Tin, W., Moddemann, D., Solimano, A., Ohlsson, A., Barrington, K.J., Roberts, R.S. JAMA (2012) [Pubmed]
  2. Long-term effects of caffeine therapy for apnea of prematurity. Schmidt, B., Roberts, R.S., Davis, P., Doyle, L.W., Barrington, K.J., Ohlsson, A., Solimano, A., Tin, W. N. Engl. J. Med. (2007) [Pubmed]
  3. Caffeine therapy for apnea of prematurity. Schmidt, B., Roberts, R.S., Davis, P., Doyle, L.W., Barrington, K.J., Ohlsson, A., Solimano, A., Tin, W. N. Engl. J. Med. (2006) [Pubmed]
  4. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). Schmidt, B., Roberts, R.S., Fanaroff, A., Davis, P., Kirpalani, H.M., Nwaesei, C., Vincer, M. J. Pediatr. (2006) [Pubmed]
  5. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial. Schmidt, B. Biol. Neonate (2005) [Pubmed]
  6. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. Schmidt, B., Asztalos, E.V., Roberts, R.S., Robertson, C.M., Sauve, R.S., Whitfield, M.F. JAMA (2003) [Pubmed]
  7. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. Schmidt, B., Davis, P., Moddemann, D., Ohlsson, A., Roberts, R.S., Saigal, S., Solimano, A., Vincer, M., Wright, L.L. N. Engl. J. Med. (2001) [Pubmed]
 
WikiGenes - Universities